Pendal Group LTD Bellus Health Inc. Transaction History

Pendal Group LTD

  • $12.2 Billion
  • Q4 2022

A detailed history of Pendal Group LTD transactions in Bellus Health Inc. stock. As of the latest transaction made, Pendal Group LTD holds 127,569 shares of BLU stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
127,569
Previous 28,328 350.33%
Holding current value
$0
Previous $299,000 250.5%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023
BUY
$8.22 - $10.76 $815,761 - $1.07 Million
99,241 Added 350.33%
127,569 $0
Q3 2022

Oct 18, 2022
BUY
$8.95 - $12.0 $253,535 - $339,936
28,328 New
28,328 $299,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email